Observational studyDrugs & aging2026
Attitudes Toward Deprescribing Among Community-Dwelling Adults: A Cross-Sectional Study in Community Pharmacies.
Observational study in Drugs & aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this study was to identify patient-related factors associated with attitudes toward deprescribing and to explore perceived barriers and facilitators among community-dwelling adults.
methodsA cross-sectional observational study was conducted in 60 community pharmacies across the Haute-Vienne and Dordogne regions of France. Eligible participants were adults aged ≥ 55 years, with at least one chronic condition and taking five or more chronic medications. Pharmacies were selected using a random cluster sampling method stratified by geographic area. Consecutively recruited patients completed an anonymous self-administered questionnaire assessing their attitudes toward deprescribing, perceived medication burden, and potential barriers or facilitators. Sociodemographic and clinical data were also collected. Multivariate logistic regression was used to identify factors associated with acceptance of deprescribing.
resultsAmong the 505 included patients (mean age 71.9 ± 9.0 years), 24.6% were reluctant to deprescribe. The main reasons for reluctance were the perceived effectiveness of their treatment (56.5%) and the fear of symptom recurrence (35.5%). Sleep disorders (odds ratio [OR] 0.51, 95% confidence interval [CI] 0.33-0.78; p = 0.002) and urinary incontinence (OR 0.58, 95% CI 0.34-0.96; p = 0.048) were significantly associated with refusal of deprescription. Perceived medication overload (OR 1.82, 95% CI 1.12-2.95; p = 0.015) and restrictive treatment burden (OR 1.76, 95% CI 1.07-2.89; p = 0.026) were significantly associated with acceptance of deprescription.
conclusionAttitudes toward deprescribing were positive among community-dwelling adults. Medication burden was associated with acceptance, whereas sleep disorders and urinary incontinence were associated with reluctance. Patient perceptions and clinical conditions should be considered when implementing deprescribing interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.